Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Efavirenz 400 mg vs 600 mg in Thai HIV-1 Infected Subjects
NCT00476424Phase 2Completed
- Sponsor
- HIV-NAT
- Start
- Jun 2007
- Primary completion
- Mar 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of efavirenz in human immunodeficiency virus infection (HIV), sponsored by HIV-NAT. Started Jun 2007; status: completed.
02
Drugs
efavirenz
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on NCT00476424.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00476424.